KG
RMD icon

Kilter Group’s ResMed RMD Stock Holding History

Kilter Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.9K Sell
20
-5
-20% -$1.04K ﹤0.01% 757
2026
Q1 		$5.61K Buy
25
+5
+25% +$1.25K ﹤0.01% 579
2025
Q4 		$4.82K Sell
20
-4
-17% -$1.02K ﹤0.01% 517
2025
Q3 		$6.57K Buy
24
+8
+50% +$2.19K ﹤0.01% 406
2025
Q2 		$4.13K Buy
+16
New +$3.82K ﹤0.01% 447

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kilter Group's RMD Position: Q2 2026 in Review

Kilter Group reduced its ResMed (RMD) stake by 20% in Q2 2026, selling an estimated $1.04K and leaving 20 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #757.

Kilter Group first reported a position in RMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.57K in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Kilter Group held 20 shares of ResMed worth $3.9K as of Q2 2026.
  • Kilter Group sold 5 ResMed shares in Q2 2026, an estimated $1.04K.
  • ResMed made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #757 holding.
  • Kilter Group first reported a position in ResMed in Q2 2025 and has held it in 5 quarters since.
  • Kilter Group's ResMed position peaked at $6.57K in Q3 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.